The estimated Net Worth of Wendy Perrow is at least 164 千$ dollars as of 10 September 2019. Ms. Perrow owns over 10,000 units of Basis Global Technologies Inc stock worth over 164,400$ and over the last 7 years she sold BASI stock worth over 0$. In addition, she makes 0$ as Independent Director at Basis Global Technologies Inc.
Wendy has made over 1 trades of the Basis Global Technologies Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 10,000 units of BASI stock worth 36,200$ on 10 September 2019.
The largest trade she's ever made was buying 10,000 units of Basis Global Technologies Inc stock on 10 September 2019 worth over 36,200$. On average, Wendy trades about 3,333 units every 0 days since 2017. As of 10 September 2019 she still owns at least 10,000 units of Basis Global Technologies Inc stock.
You can see the complete history of Ms. Perrow stock trades at the bottom of the page.
Wendy Perrow is Independent Director of the Company. Ms. Perrow is President and Chief Executive Officer at Alba Therapeutics. Ms. Perrow joined Alba Therapeutics in 2008 as Vice President, Business Development, Marketing and Alliance Management. She was appointed President and Chief Operating Officer in 2011 and named Chief Executive Officer in 2013. Prior to joining Alba Therapeutics, Ms. Perrow held senior executive marketing positions with private and public pharmaceutical companies. From 2004 to 2007, she was Vice President of Marketing for Sigma-Tau Pharmaceuticals, Inc. From 1989 to 2003, Ms. Perrow held positions at Merck and Co., Inc. in marketing promotion, international business research analysis, training, and sales. Ms. Perrow began her career in a division of Johnson & Johnson. Ms. Perrow holds a bachelor’s degree from Eastern Illinois University and a Masters of Business Administration degree in finance and marketing from Duke University - The Fuqua School of Business. Through her extensive experience, Ms. Perrow brings knowledge and insight of the pharmaceutical industry as well as management expertise.
Wendy Perrow is 57, she's been the Independent Director of Basis Global Technologies Inc since 2015. There are 1 older and 3 younger executives at Basis Global Technologies Inc. The oldest executive at Basis Global Technologies Inc is Richard Johnson, 70, who is the Independent Director.
Wendy's mailing address filed with the SEC is C/O BIOANALYTICAL SYSTEMS, INC., 2701 KENT AVENUE, WEST LAFAYETTE, IN, 47906.
Over the last 21 years, insiders at Basis Global Technologies Inc have traded over 266,443$ worth of Basis Global Technologies Inc stock and bought 540,162 units worth 1,698,287$ . The most active insiders traders include Jacqueline M Lemke、Robert Jr. Leasure、William D Pitchford. On average, Basis Global Technologies Inc executives and independent directors trade stock every 65 days with the average trade being worth of 128,544$. The most recent stock trade was executed by Beth Taylor on 5 March 2021, trading 5,000 units of BASI stock currently worth 88,500$.
Basis Global Technologies Inc executives and other stock owners filed with the SEC include: